COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial

The SARS-CoV-2 pandemic had a devastating impact on the world’s population in the years 2020–2022. The rapid development of vaccines enabled a reduction in the mortality and morbidity of COVID-19, but there are limited data about their effects on immunocompromised children. The aim of this prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Matkowska-Kocjan, Agnieszka, Owoc-Lempach, Joanna, Ludwikowska, Kamila, Szenborn, Filip, Moskwa, Natalia, Kurek, Katarzyna, Kałwak, Krzysztof, Szenborn, Leszek, Ussowicz, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866698/
https://www.ncbi.nlm.nih.gov/pubmed/36680039
http://dx.doi.org/10.3390/vaccines11010195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866698/
https://www.ncbi.nlm.nih.gov/pubmed/36680039
http://dx.doi.org/10.3390/vaccines11010195

Ejemplares similares